Results 11 to 20 of about 114,567,637 (316)

An outbreak of hepatitis A associated with salted clams in Busan, Korea [PDF]

open access: yesEpidemiology and Health, 2021
OBJECTIVES In July 2019, there were multiple reports on patients with hepatitis A among the visitors of a restaurant in Busan. The current study presents the results of an epidemiological investigation and outlines the supplementary measures that would ...
Hyunjin Son   +7 more
doaj   +1 more source

The Change in the Susceptible Populations with the Shift in Hepatitis A Epidemiology

open access: yesDüzce Tıp Fakültesi Dergisi, 2022
Aim: The incidence of hepatitis A (HepA) has decreased due to vaccination and improved hygiene conditions. However, the age of onset of the disease has shifted from childhood to adulthood.
Feruze Enç   +4 more
doaj   +1 more source

Hepatitis A Outbreak in a Facility for the Disabled, Gyeonggi Province, Korea: An Epidemiological Investigation [PDF]

open access: yesJournal of Preventive Medicine and Public Health, 2021
Objectives: The number of cases of hepatitis A virus (HAV) infections has sharply increased in Korea, especially among young adults. In this study, an HAV outbreak in a facility for disabled people was investigated, and we found epidemiological ...
Yeonhwa Chang   +4 more
doaj   +1 more source

Simultaneous infection of amoebic liver abscess and hepatitis A infection in a young adult in an endemic region

open access: yesJournal of Family Medicine and Primary Care, 2022
Concomitant hepatitis A virus (HAV) and amoebic liver abscess are to be considered in patients with clinical signs and symptoms of fever, jaundice, and right upper quadrant pain, especially in endemic areas.
Saurabh Puri   +4 more
doaj   +1 more source

Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002: a review

open access: yesMemorias do Instituto Oswaldo Cruz, 2006
The prevalence of hepatitis A virus (HAV) infection is high in developing countries, in which low standards of sanitation promote the transmission of the virus.
Cláudia L Vitral   +2 more
doaj   +1 more source

Sustained false-positive results for hepatitis A virus immunoglobulin M: A case report and literature review

open access: yesOpen Medicine, 2021
Hepatitis A virus immunoglobulin M (HAV-IgM) is often used to diagnose acute hepatitis A virus (HAV) infection serologically. However, false-positive test results can interfere with the diagnosis.
Tan Youwen, Chen Li
doaj   +1 more source

Hepatitis [PDF]

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2001
Worldwide, approximately 170 million people are chronically infected with hepatitis C virus (HCV) and another 350 million individuals are chronically infected with hepatitis B virus (HBV) (1,2). Canada is estimated to have 240,000 to 300,000 HCV and 200,000 to 280,000 HBV chronic carriers (3,4).
openaire   +3 more sources

Quantitative image-based collagen structural features predict the reversibility of hepatitis C virus-induced liver fibrosis post antiviral therapies

open access: yesScientific Reports, 2023
The novel targeted therapeutics for hepatitis C virus (HCV) in last decade solved most of the clinical needs for this disease. However, despite antiviral therapies resulting in sustained virologic response (SVR), a challenge remains where the stage of ...
Laurent Gole   +11 more
doaj   +1 more source

Tracking Virus-Specific CD4+ T Cells during and after Acute Hepatitis C Virus Infection [PDF]

open access: yes, 2007
Background. CD4+ T cell help is critical in maintaining antiviral immune responses and such help has been shown to be sustained in acute resolving hepatitis C.
Paul Klenerman   +175 more
core   +2 more sources

Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Hepatitis A is a vaccine-preventable infection caused by the HA virus (HAV) with transitional to intermediate endemicity in China. An inactivated vaccine first licensed in China in 2010 (Avaxim® 80U Pediatric) is indicated for primary and booster ...
Nianmin Shi, Anvar Rasuli, Yaël Thollot
doaj   +1 more source

Home - About - Disclaimer - Privacy